Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease

ABSTRACT Background Neurofilament light chain protein (NfL) is a promising biomarker of neurodegeneration. Objectives To determine whether plasma and CSF NfL (1) associate with motor or cognitive status in Parkinson's disease (PD) and (2) predict future motor or cognitive decline in PD. Methods...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Movement disorders Ročník 36; číslo 12; s. 2945 - 2950
Hlavní autori:	Aamodt, Whitley W., Waligorska, Teresa, Shen, Junchao, Tropea, Thomas F., Siderowf, Andrew, Weintraub, Daniel, Grossman, Murray, Irwin, David, Wolk, David A., Xie, Sharon X., Trojanowski, John Q., Shaw, Leslie M., Chen‐Plotkin, Alice S.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Hoboken, USA John Wiley & Sons, Inc 01.12.2021 Wiley Subscription Services, Inc
Predmet:	Biomarkers Biomarkers - cerebrospinal fluid Cerebrospinal fluid Cognition Cognitive ability Cognitive Dysfunction - cerebrospinal fluid Cognitive Dysfunction - diagnosis Cognitive Dysfunction - etiology Cross-Sectional Studies Dementia Dementia disorders Disease Progression Humans Intermediate Filaments - metabolism Medical prognosis Movement disorders Neurodegeneration Neurodegenerative diseases neurofilament light chain protein NfL Parkinson Disease - complications Parkinson Disease - diagnosis Parkinson's disease Plasma prognosis Regression analysis Parkinson's disease neurofilament light chain protein NfL prognosis biomarkers
ISSN:	0885-3185, 1531-8257, 1531-8257
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!